Market movers: The Investment Committee’s top stocks to watch right now. Read more
Cnbc - Dec 17
Advisors Capital Management LLC increased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 591,096 shares of the company’s stock after ... Read more
Americanbankingnews - Nov 14
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to corporate offices and manufacturing sites for AbbVie. Read more
Chicago Tribune - Aug 12
AbbVie Inc. (NYSE:ABBV), the manufacturer of Imbruvica, is at the center of a constitutional challenge to the federal government's new Drug Price Negotiation Program. Imbruvica was among the first 10 drugs selected for price negotiations under the Inflation Reduction Act of 2022. The law gave the... Read more
Benzinga - Aug 08
Genmab A/S (NASDAQ:GMAB) released results Thursday of the Phase 3 EPCORE FL-1 trial evaluating subcutaneous epcoritamab in combination with rituximab and lenalidomide (R2) versus R2 alone for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL).The study met its dual primary ... Read more
Benzinga - Aug 08
